Skip to content

SLDB - Solid Biosciences Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchS

Solid Biosciences LLC

SLDB · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

S

SLDBSolid Biosciences LLC

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $11.45
52-wk low: $3.79
Prev close: $7.71
Mkt cap: $1.04B
Beta: 2.42
P/S: 3.6x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$222.8M

CI
Citadel
Ken Griffin · Q2 2026 13F
$28.1M
position
P7
Point72
Steven Cohen · Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $1.0B

Valuation

P/S3.65
P/B2.60

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: SLDB
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $1.04B
Beta: 2.42

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

2.6x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-65.5%

$4.5M

position

MI

Millennium

Israel Englander · Q1 2026 13F

$2.6M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for SLDB

No recent insider trade
No recent Congress trade
No recent market-voice mention

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

What the street expects next

EPS expected

-$0.42

-$0.53 to -$0.34

Revenue expected

$0.00

11 analysts

Last 30 days

2up9down

Analysts cutting estimates

Estimate drift

+0.06

Change in 30 days

-65.5%

ROA-36.4%

Growth

Beta2.42